Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicola L Hurst

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Thrombosis Research|June 22, 2015
Determinants of subacute response to clopidogrel: relative impact of CYP2C19 genotype and PGE1/adenylate cyclase signallingNicola L Hurst, Vivek B Nooney, Yuliy Y Chirkov, et al.
Thrombosis Research|October 22, 2020
Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel?Vivek B Nooney, Nicola L Hurst, Raffaele De Caterina, et al.
Cardiovascular Drugs and Therapy|July 1, 2016
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic ImplicationsNathan E K Procter, Nicola L Hurst, Vivek B Nooney, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Thrombosis Research|June 22, 2015
Determinants of subacute response to clopidogrel: relative impact of CYP2C19 genotype and PGE1/adenylate cyclase signallingNicola L Hurst, Vivek B Nooney, Yuliy Y Chirkov, et al.
Thrombosis Research|October 22, 2020
Does high on-treatment platelet aggregability reflect poor individual response to clopidogrel?Vivek B Nooney, Nicola L Hurst, Raffaele De Caterina, et al.
Cardiovascular Drugs and Therapy|July 1, 2016
New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic ImplicationsNathan E K Procter, Nicola L Hurst, Vivek B Nooney, et al.
Pageof 1